Metformina Accordpharma

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Metformina Accordpharma (Metformin Hydrochloride)

Q: What is Metformina Accordpharma used for?

Metformina Accordpharma contains metformin hydrochloride and is prescribed to improve blood‑sugar control in adults with type 2 diabetes mellitus. It may also be used in prediabetes and, where appropriate, in polycystic ovary syndrome to address insulin resistance.

Q: How does metformin work in the body?

Metformin acts by activating AMP‑activated protein kinase, which reduces hepatic glucose production, decreases intestinal glucose absorption, and enhances peripheral insulin sensitivity. These combined actions lower circulating glucose levels without directly stimulating insulin secretion.

Q: What is the usual dose of Metformina Accordpharma?

The specific dose of Metformina Accordpharma is determined by the prescribing clinician based on the patient’s renal function, glycemic targets, and overall health status. The prescriber will select the appropriate strength and titration schedule.

Q: Is Metformina Accordpharma safe during pregnancy or breastfeeding?

Metformin crosses the placenta and is classified as a pregnancy‑category drug only when benefits outweigh risks. It is sometimes continued in gestational diabetes under medical supervision. During breastfeeding, small amounts are excreted in milk; clinicians should evaluate safety on a case‑by‑case basis.

Q: How do I order Metformina Accordpharma from GNH India?

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Q: How does Metformina Accordpharma compare with other antidiabetic drugs?

Metformin is the first‑line therapy for type 2 diabetes due to its efficacy, low risk of hypoglycemia, and weight‑neutral profile. Compared with sulfonylureas or insulin, it does not stimulate insulin release, reducing hypoglycemia risk, and it has a favorable cardiovascular safety record.

Q: What are the storage and handling requirements for Metformina Accordpharma?

Metformina Accordpharma should be stored at temperatures below 25 °C, in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use if the packaging is damaged.

Q: How is Metformina Accordpharma administered?

The medication is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water. The exact timing and frequency are set by the prescribing healthcare professional.

Q: What are the most serious risks associated with Metformina Accordpharma?

The most serious adverse effect is lactic acidosis, a rare but potentially fatal condition, especially in patients with severe renal or hepatic impairment. Other serious risks include severe skin reactions such as Stevens‑Johnson syndrome and significant vitamin B12 deficiency with long‑term use.

Q: Who should not use Metformina Accordpharma?

Metformina Accordpharma is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with known hypersensitivity to metformin or any component of the formulation.

Metformin, the active ingredient in Metformina Accordpharma, is a biguanide presented as a unknown/unknown for oral use. It treats type 2 diabetes mellitus in adults by improving blood‑sugar control.
GNH India supplies Metformina Accordpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Accord Healthcare S.L.U.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformina Accordpharma is indicated for conditions within the glucose‑regulation pathway.

Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels.
Prediabetes: helps delay progression to overt diabetes when combined with lifestyle measures.
Polycystic ovary syndrome (PCOS): reduces insulin resistance and may improve menstrual regularity.

How It Works

Metformin lowers blood glucose primarily by inhibiting hepatic gluconeogenesis, decreasing intestinal glucose absorption, and enhancing peripheral insulin sensitivity through activation of AMP‑activated protein kinase (AMPK) pathways, leading to reduced hepatic glucose output and improved glucose uptake in muscle and adipose tissue.

Side Effects

Metformina Accordpharma may cause a range of adverse reactions.

Common Side Effects

Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite.
Diarrhea: frequent loose stools, especially during treatment initiation.
Metallic taste: transient alteration in taste perception.
Flatulence: increased intestinal gas.
Weight loss: modest reduction in body weight.
Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects

Lactic acidosis: rare but life‑threatening metabolic disturbance.
Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
Hepatic dysfunction: elevated liver enzymes or hepatitis.
Hypoglycemia: when combined with insulin or secretagogues.
Anemia: due to folate deficiency.
Electrolyte imbalance: especially with prolonged diarrhea.

Precautions & Warnings

Metformina Accordpharma requires careful monitoring in several clinical situations.

Renal function assessment: avoid use in severe renal impairment (eGFR <30 mL/min/1.73 m²).
Hepatic function monitoring: use cautiously in patients with liver disease.
Blood glucose monitoring: adjust therapy based on glycemic response.
Elderly patients: start at lower dose and titrate slowly.
Heart failure: evaluate risk of lactic acidosis in unstable patients.
Store at below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Metformina Accordpharma can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid)

Iodinated contrast agents: increase risk of acute kidney injury and lactic acidosis.
Cimetidine: may raise metformin plasma concentrations.
Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

Beta‑blockers: may mask hypoglycemia symptoms.
Diuretics: can affect renal clearance of metformin.
ACE inhibitors or ARBs: monitor renal function and potassium.
Calcium channel blockers: may modestly increase metformin levels.
Oral contraceptives: may slightly raise plasma metformin concentrations.

Frequently Asked Questions

Metformina Accordpharma contains metformin hydrochloride and is prescribed to improve blood‑sugar control in adults with type 2 diabetes mellitus. It may also be used in prediabetes and, where appropriate, in polycystic ovary syndrome to address insulin resistance.

Metformin acts by activating AMP‑activated protein kinase, which reduces hepatic glucose production, decreases intestinal glucose absorption, and enhances peripheral insulin sensitivity. These combined actions lower circulating glucose levels without directly stimulating insulin secretion.

The specific dose of Metformina Accordpharma is determined by the prescribing clinician based on the patient’s renal function, glycemic targets, and overall health status. The prescriber will select the appropriate strength and titration schedule.

Metformin crosses the placenta and is classified as a pregnancy‑category drug only when benefits outweigh risks. It is sometimes continued in gestational diabetes under medical supervision. During breastfeeding, small amounts are excreted in milk; clinicians should evaluate safety on a case‑by‑case basis.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metformin is the first‑line therapy for type 2 diabetes due to its efficacy, low risk of hypoglycemia, and weight‑neutral profile. Compared with sulfonylureas or insulin, it does not stimulate insulin release, reducing hypoglycemia risk, and it has a favorable cardiovascular safety record.

Metformina Accordpharma should be stored at temperatures below 25 °C, in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use if the packaging is damaged.

The medication is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water. The exact timing and frequency are set by the prescribing healthcare professional.

The most serious adverse effect is lactic acidosis, a rare but potentially fatal condition, especially in patients with severe renal or hepatic impairment. Other serious risks include severe skin reactions such as Stevens‑Johnson syndrome and significant vitamin B12 deficiency with long‑term use.

Metformina Accordpharma is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with known hypersensitivity to metformin or any component of the formulation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 06 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.